(Q33257142)

24 July 2017

title

Breast cancer risk associated with different HRT formulations: a register-based case-control study (English)

1 reference

Hormone Replacement Therapy

24 July 2017

main subject

1 reference

Juergen C Dinger

1

1 reference

24 July 2017

Lothar A J Heinemann

2

1 reference

24 July 2017

Sabine Möhner

3

1 reference

24 July 2017

Do Minh Thai

4

1 reference

24 July 2017

Anita Assmann

5

1 reference

24 July 2017

publication date

12 September 2006

1 reference

24 July 2017

1 reference

24 July 2017

volume

6

1 reference

24 July 2017

page(s)

13

1 reference

Hormone replacement therapy: pathobiological aspects of hormone-sensitive cancers in women relevant to epidemiological studies on HRT: a mini-review

24 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Hormones and breast cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Breast cancer and hormone-replacement therapy in the Million Women Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Genetic testing for breast and ovarian cancer for women with a family history of breast cancer: weighing conflicting evidence about oral contraceptives.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Breast cancer hypothesis: a single cause for the majority of cases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

HRT and cancer risk: separating fact from fiction

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Reproducibility of oral contraceptive histories and validity of hormone composition reported in a cohort of US women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Cancer risk in women receiving estrogen-progestin replacement therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Comparison of recalled and validated oral contraceptive histories

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

The ability of women to recall their oral contraceptive histories

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Effect of estrone sulfate on postmenopausal bone loss

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Reproductive factors, exogenous female hormones, and colorectal cancer by subsite

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Hormone therapy to prevent disease and prolong life in postmenopausal women

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Risks of estrogen plus progestin therapy: a sensitivity analysis of findings in the Women's Health Initiative randomized controlled trial

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

Relationship between long durations and different regimens of hormone therapy and risk of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

A prospective study of different types of hormone replacement therapy use and the risk of subsequent breast cancer: the women's health in the Lund area (WHILA) study (Sweden)

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

Increased risk of breast cancer following different regimens of hormone replacement therapy frequently used in Europe

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6874-6-13

Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1574290

Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16965641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16965641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Exogenous hormone use and the risk of postmenopausal breast cancer: results from the Netherlands Cohort Study

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16965641

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6874-6-13

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference